Forecast & Rating3 analysts currently cover Edesa Biotech, of which 2 give a positive rating. The average price target is $16.33, about 301.3% upside from the current price of $4.07. Coverage is limited, so the data is for reference only. Data as of Aug 24, 2026; this does not constitute investment advice.
Aug 24, 2026Price forecast
$16.33301.31%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met24.2%
Stock price$4.07
Avg. target$11.0
High target$19
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.